Published May 7, 2012
The Turner Padget Graham & Laney P.A. law firm launched a drug and medical device practice group.
The practice group will handle complex litigation claims, intellectual property matters, fraud investigations and regulatory actions.
In the past, Turner Padget attorneys have worked on cases involving Phenylpropanolamine, Rezulin, Abilify, chlorine, silica, tobacco, Ephedra, insulin and hormone replacement therapy. Additionally, Turner Padget lawyers have experience representing medical device manufacturers in a wide range of product defect claims. Team members have defended manufacturers of surgical lasers, catheters, prosthetics, artificial joints, isomeric infusion devices, total disk replacement devices, and silicone and saline implants.
“While the formalization of this industry group is a new concept for us, our service to these industries is deeply rooted in our history as a leading trial firm,” said Richard S. Dukes, a Turner Padget shareholder and member of the drug and medical device practice group. “Collaborating as a group allows us the opportunity to serve clients in this sector efficiently and to share our strengths in both litigation and transactional services to clients in the pharmaceutical and medical device industries.”
Founded in 1929, Turner Padget has more than 90 attorneys and five offices in Charleston, Columbia, Florence, Greenville and Myrtle Beach.